Skip to main content

Table 1 Patient characteristics

From: Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy

 

Total (n = 74)

NLR < 2.38

NLR ≥ 2.38

p-value

Age

<65 years

32 (43.2 %)

24 (52.9 %)

8 (34.8 %)

0.324

≥65 years

42 (56.8 %)

27 (47.1 %)

15 (65.2 %)

Gender

Female

16 (21.6 %)

11 (21.6 %)

5 (21.7 %)

0.987

Male

58 (78.4 %)

40 (78.4 %)

18 (78.3 %)

ECOG-PS

0

68 (91.9 %)

48 (94.1 %)

20 (87.0 %)

0.270

≥1

6 (8.1 %)

3 (5.9 %)

3 (13.0 %)

Neoadjuvant Chemotherapy

No

64 (86.5 %)

45 (88.2 %)

19 (82.6 %)

0.847

Yes

10 (13.5 %)

6 (11.8 %)

4 (17.4 %)

Clinical T stage

≤2

38 (51.4 %)

26 (51.0 %)

12 (52.2 %)

0.924

≥3

36 (48.6 %)

25 (49.0 %)

11 (47.8 %)

Clinical Lymph Node Metastasis

No

70 (94.6 %)

48 (94.1 %)

22 (95.7 %)

0.633

Yes

4 (5.4 %)

3 (5.9 %)

1 (4.3 %)

Surgical Margin

Negative

68 (91.9 %)

45 (88.2 %)

23 (100.0 %)

0.097

Positive

6 (8.1 %)

6 (11.8 %)

0 (0.0 %)

Adjuvant chemotherapy

No

49 (66.2 %)

35 (68.6 %)

14 (60.9 %)

0.514

Yes

25 (33.8 %)

16 (31.4 %)

9 (39.1 %)

Pathological T stage

≤2

53 (71.6 %)

37 (72.5 %)

16 (69.6 %)

0.792

≥3

21 (28.4 %)

14 (27.5 %)

7 (30.4 %)

Pathological Lymph Node Metastasis

No

64 (86.5 %)

43 (84.3 %)

21 (91.3 %)

0.339

Yes

10 (13.5 %)

8 (15.7 %)

2 (8.7 %)

  1. ECOG-PS Eastern Cooperative Oncology Group performance status